Lisa von Wald
Nurse Practitioner · Minneapolis, MNNPI 1093147142
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 77.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $4,564 and has fallen 79.7% since, to $928 in 2025. Among nurse practitioner clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $82.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Boston Scientific$2K
- Biosense Webster, Inc.$179
- Impulse Dynamics (USA) Inc.$86
- Heartflow, Inc.$33
- Biotronik Inc.$16
What the payments were for
- Travel & lodging$4,85846%
- Food & beverage$5,62954%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 111 | $8,153 |
| Boston Scientific | 11 | $2,035 |
| Biosense Webster, Inc. | 3 | $179 |
| Impulse Dynamics (USA) Inc. | 1 | $86 |
| Heartflow, Inc. | 1 | $33 |
| Biotronik Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINQ II$656
- COBALT DR MRI SURESCAN$429
- Micra$351
- Farapulse$133
- GENERAL - THERAPIES$128
- EMPOWER Leadless Pacemaker System_CRM$107
- Carto 3$105
How this compares
$10,503 in reported general payments places this provider in the 95th percentile of 3,021 nurse practitioner providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 216 | $289,219 |
| XareltoRivaroxaban | 111 | $153,691 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 21 | $5,049 |
| Metoprolol Succinate | 193 | $3,768 |
| Dofetilide | 11 | $2,684 |
| Flecainide Acetate | 47 | $2,647 |
| Amiodarone Hcl | 119 | $2,599 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 57 | $2,010 |
| Warfarin Sodium | 33 | $889 |
| SotalolSotalol Hcl | 40 | $859 |
| Dilt-XrDiltiazem Hcl | 20 | $779 |
| Atorvastatin Calcium | 50 | $683 |
| Carvedilol | 64 | $617 |
| Lisinopril | 52 | $569 |
| Metoprolol Tartrate | 52 | $463 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Minneapolis
- Margaret VolzMinneapolis$30K
- Natasha TennessenMinneapolis$6K
- Laurie LarsonMinneapolis$5K
- Anne BoisclairefaheyMinneapolis$4K
- Teresa BertozziMinneapolis$4K
- Jesse BachMinneapolis$4K
- Morgan PopeMinneapolis$3K
- Randy PetersonMinneapolis$2K
- Jill ToliverWoodbury$116K
- Rebecca SuessBurnsville$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.